Cargando…

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study

OBJECTIVE: To evaluate the efficacy of a novel and selective β3‐adrenoreceptor agonist vibegron on urgency urinary incontinence (UUI) in patients with overactive bladder (OAB). PATIENTS AND METHODS: A post hoc analysis was performed in patients with UUI (>0 episodes/day) who were assigned to rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Masaki, Takeda, Masayuki, Gotoh, Momokazu, Yokoyama, Osamu, Kakizaki, Hidehiro, Takahashi, Satoru, Masumori, Naoya, Nagai, Shinji, Minemura, Kazuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Functional Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318146/ https://www.ncbi.nlm.nih.gov/pubmed/31991511 http://dx.doi.org/10.1111/bju.15020

Ejemplares similares

Efficacy of novel β(3)‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2018)

Cardiovascular safety of vibegron, a new β3‐adrenoceptor agonist, in older patients with overactive bladder: Post‐hoc analysis of a randomized, placebo‐controlled, double‐blind comparative phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2021)

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013)

Vascular risk factors for male and female urgency urinary incontinence at age 68 years from a British birth cohort study
por: Tsui, Alex, et al.
Publicado: (2018)

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009)

A novel approach to overactive bladder syndrome treatment
por: Szalecki, Paweł
Publicado: (2014)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Urinary incontinence and sexual health in a population sample of older people
por: Lee, David M., et al.
Publicado: (2018)

Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training
por: Sjöström, Malin, et al.
Publicado: (2013)

Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training
por: Sjöström, Malin, et al.
Publicado: (2015)

Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report
por: Kato, Taiki, et al.
Publicado: (2021)

Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study
por: Yoshida, Masaki, et al.
Publicado: (2022)

Efficacy of mirabegron, a β(3)‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies
por: Takahashi, Satoru, et al.
Publicado: (2021)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Editorial Comment: Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function
por: Riccetto, Cássio L. Z.
Publicado: (2020)

Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
por: Chen, Jing Voon, et al.
Publicado: (2022)

Do urologists need an orthodontist in order to optimize the treatment of nocturnal enuresis?
por: Juszczak, Kajetan
Publicado: (2014)

The presence of LUTS is not a decisive tool for deciding who should be qualified for prostate biopsy
por: Juszczak, Kajetan
Publicado: (2014)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Antifungal azoles – new antidote for chronic pelvic pain?
por: Dybowski, Bartosz
Publicado: (2013)

Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
por: Fode, Mikkel, et al.
Publicado: (2014)

Not only diabetic polyneuropathy but also interstitial cells of Cajal dysfunction is a potential mechanism for diabetic cystopathy
por: Juszczak, Kajetan
Publicado: (2014)

Laparoscopic simple prostatectomy, a lost child of laparoscopic surgery
por: Rivas, Juan Gómez, et al.
Publicado: (2014)

Lymphangiomatous endothelial cyst of the adrenal gland: A case report
por: Issam, Rekik, et al.
Publicado: (2021)

Rapid growth of a large penile median raphe cyst
por: McNall, Shannon, et al.
Publicado: (2021)

Inguinoscrotal herniation of bladder and ureter: A case report
por: Allameh, Farzad, et al.
Publicado: (2021)

A rare complication of suprapubic catheterisation with obstruction and significant migration into a ureter
por: Saad, Jeremy, et al.
Publicado: (2021)

Giant bladder diverticulum in a postmenopausal woman: Case report and literature review
por: Sow, Ousmane, et al.
Publicado: (2021)

Giant hydronephrosis secondary to ureteropelvic junction obstruction, a rare occurrence, case report
por: Hassen, Seid Mohammed, et al.
Publicado: (2021)

Pelvic ligament repair with slings – a foundation stone for solution of the ageing crisis in female pelvic urology
por: Petros, Peter Emanuel
Publicado: (2021)

Diagnosis and management of testicular compartment syndrome caused by tension hydrocele
por: Chen, Irene, et al.
Publicado: (2022)

Ureterocele mimicking uterine polyp in a young woman presenting with a vulvar mass: A case report
por: Mirazimi, Maryam Sadat, et al.
Publicado: (2022)

Retroperitoneal hematoma post percutaneous sacral nerve evaluation: A case report
por: Aldossary, Nader A., et al.
Publicado: (2022)

A case report of the preferred indication for the Zephyr (ZSI 375) artificial urinary sphincter
por: Basiri, Abbas, et al.
Publicado: (2022)

An unusual case of spontaneous rupture of the renal pelvis
por: Weber, Theodore, et al.
Publicado: (2022)

Torsed spermatocele, a rare cause of acute scrotum: Report of a case and review of literature
por: Gebreselassie, Kaleab Habtemichael, et al.
Publicado: (2022)

An extremely rare case of pseudomelanosis of the urinary bladder
por: Duijn, M., et al.
Publicado: (2022)

Complex vesical diverticulum, an unusual cause of obstructive uropathy
por: Zubenko Stepanova, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3i0f6n9anbnl228fd67vtkr5p3